Effect of Evolocumab on Coronary Endothelial Function

NCT03500302 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus
Coronary Artery Disease

Interventions

DRUG: Evolocumab

Sponsor

Johns Hopkins University

Collaborators

[object Object]